Certain Options of Verve Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024. These Options will be under lockup for 61 days starting from 28-NOV-2023 to 28-JAN-2024.

Details:
Directors and executive officers, and certain of significant stockholders (such persons, the ?lock-up parties?) have entered into lock up agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for a period of 60 days after the date of this prospectus supplement (such period, the ?restricted period?), may not (and may not cause any of their direct or indirect affiliates to), without the prior written consent of Jefferies LLC and Guggenheim Securities, LLC.